Consistent with previous reports BRCA mutations in breast cancer were mostly associated with regulation of cell cycle, DNA damage, and cell proliferation in breast cancer [71], and with immune system-related processes in ovarian cancer [61], which may be an indicator of differential role of BRCA1 and BRCA2 in the pathogenesis of these diseases. This evidence concerns the gene BRCA2 and ovarian carcinoma.